Detalhe da pesquisa
1.
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Blood
; 141(7): 756-765, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327160
2.
Single-Cell Sequencing Technologies in Precision Oncology.
Adv Exp Med Biol
; 1361: 269-282, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230694
3.
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
J Clin Invest
; 134(8)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376944
4.
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Blood Adv
; 7(6): 1056-1064, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018226
5.
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma.
JCO Precis Oncol
; 6: e2200147, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704796
6.
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.
Sci Adv
; 7(47): eabg9551, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788103
7.
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma.
Leuk Lymphoma
; 61(9): 2208-2215, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812822